By rray, 22 February, 2024 Air travel If resting sat 95 w 6 min walk sat 84 air travel OK however severe hypoxemia in air travel may occur despite sea level sat C
By rray, 22 February, 2024 If placed on long term O2 titrate to keep sat 90 re evaluate at 60 90 days w pulse ox ABG
By rray, 22 February, 2024 If stable COPD w only moderate resting exercise induced desaturation no benefit to O2 A
By rray, 22 February, 2024 Offer pulmonary rehab A Encourage physical activity improves SOB health status exercise tolerance in stable COPD A reduces hospitalization in pts w recent exac B Optimum benefits seen from 6 to 8 wk program no evidence supports 12wk Twice weekly supervise
By rray, 22 February, 2024 Give long acting inhaled BD combo LABA LAMA plus short acting rescue BD inhaled is preferred vs oral A LABAs and LAMAs improve dyspnea reduce exac rate A LAMAs reduce exac A and hospitalizations B more than LABAs combos more effective than mono tx B Tailo
By rray, 22 February, 2024 LABA LAMA nbsp nbsp LABA options arformoterol formoterol olodaterol salmeterol nbsp nbsp LAMA options aclidinium glycopyrrolate revefenacin tiotropium DPI MDI umeclidinium nbsp nbsp LAMA LABA combo options aclidinium formoterol glycopyrrolate formoterol t
By rray, 22 February, 2024 Rescue short acting BD SABA or SAMA for immediate sx relief SABA options albuterol levalbuterol MDI NEB SAMA ipratropium MDI NEB
By rray, 22 February, 2024 Treatments w no or uncertain benefits oral steroids C antitussives C vasodilators B drugs for primary pulm HTN B mepolizumab benralizumab dupilumab nedocromil leukotriene modifiers infliximab immunostimulants beta blockers if no CV indication for use simv
By rray, 22 February, 2024 Follow COVID 19 mitigation strategies and test for SARS CoV 2 if warranted e g new or worsening resp sx fever loss of taste and or smell If SARS CoV 2 pos continue usual COPD meds